Ritchie Meg, Yeap Bu B
Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals, Perth, Western Australia, Australia.
Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals, Perth, Western Australia, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
Maturitas. 2015 Jun;81(2):266-75. doi: 10.1016/j.maturitas.2015.03.016. Epub 2015 Mar 28.
The association of thyroid dysfunction with alterations in mood and cognition has been recognised since some of the earliest descriptions of thyroid disease. Over the years, researchers have aimed to further define these effects throughout the spectrum of thyroid disorders, to better understand the underlying condition and refine indications for treatment. More recently, attention has turned towards examining the impact of differences in thyroid hormones within the normal reference range, particularly in older adults, providing new insights into the association of thyroid hormone with cognitive decline. This review summarises the evidence assessing the influence of thyroid hormone on mood and cognition in overt and subclinical hypothyroidism, within the reference range, and in subclinical and overt hyperthyroidism. Treatment of overt thyroid dysfunction largely resolves associated disturbances in mood and cognitive dysfunction, however in the setting of overt hypothyroidism subtle detrimental effects on cognition may not be fully reversed. Subclinical hyperthyroidism and higher free thyroxine (FT4) within the normal range have been associated with poorer cognitive outcomes. Future research including randomised controlled trials are required to confirm causality and guide the assessment of benefits vs risks of intervention in the increasing population of older adults with subclinical thyroid disease.
自甲状腺疾病最早被描述以来,甲状腺功能障碍与情绪和认知改变之间的关联就已被认识到。多年来,研究人员一直致力于在整个甲状腺疾病谱中进一步明确这些影响,以便更好地了解潜在病情并完善治疗指征。最近,注意力转向了研究正常参考范围内甲状腺激素差异的影响,尤其是在老年人中,这为甲状腺激素与认知衰退之间的关联提供了新的见解。本综述总结了评估甲状腺激素对显性和亚临床甲状腺功能减退、参考范围内以及亚临床和显性甲状腺功能亢进患者的情绪和认知影响的证据。显性甲状腺功能障碍的治疗在很大程度上可解决相关的情绪和认知功能障碍,但在显性甲状腺功能减退的情况下,对认知的细微有害影响可能无法完全逆转。亚临床甲状腺功能亢进和正常范围内较高的游离甲状腺素(FT4)与较差的认知结果相关。未来需要开展包括随机对照试验在内的研究,以确认因果关系,并指导对越来越多患有亚临床甲状腺疾病的老年人进行干预的利弊评估。